[1]
« Hypertension as a Cardiovascular Toxicity of Bruton’s Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia », Can Hematol Today, vol. 4, nᵒ s03, p. 2–12, mai 2025, doi: 10.58931/cht.2025.4s0368.